Changing nature of cardiac interventions in older adults

Area of Science:

• Gerontology
• Cardiology
• Clinical Trials

Background:

• Older adults are a growing demographic with increased cardiovascular disease (CVD) risk and mortality.
• Established CVD procedures were validated in younger populations and are now applied to older adults, who are underrepresented in clinical trials.
• While age isn't a contraindication, older adults often have multiple comorbidities and complex physiological profiles.

Purpose of the Study:

• To highlight the increasing application of CVD interventions in older adults.
• To underscore the need for research that specifically addresses the unique challenges and benefits of treating CVD in the elderly.
• To inform future research directions balancing intervention risks with quality of life and functional outcomes.

Main Methods:

• Review of current clinical practices and existing literature on CVD interventions in older adults.
• Analysis of the underrepresentation of older adults in clinical trials for procedures like percutaneous coronary intervention and aortic valve replacement.
• Consideration of less invasive percutaneous techniques for managing coronary artery disease and valvular heart disease.

Main Results:

• CVD interventions initially validated in younger populations are increasingly performed on older adults.
• Older adults with CVD are significantly understudied in clinical trials, leading to a lack of specific evidence.
• Less invasive percutaneous techniques offer new management options for CVD in this demographic.

Conclusions:

• Advanced age alone should not be a contraindication for CVD procedures.
• Future research must carefully weigh the potential harms of interventions against benefits such as preventing functional decline and improving quality of life in older adults.
• There is a critical need for clinical trials that include diverse older populations with complex health profiles to guide evidence-based treatment strategies.